Externally used liquid preparation containing only iridoid glycoside and application thereof

A technology of iridoid glycosides and liquid preparations, applied in the fields of sprays, aerosols, lotions, ointments and liniments of unique iridoid glycosides, can solve the problems of low bioavailability, low drug concentration, Slow onset of action and other problems, to achieve the effect of good patient compliance, high drug concentration, and low production cost

Inactive Publication Date: 2010-06-23
HENGKANG MEDICAL GROUP CO LTD
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the shortcomings of the oral preparation itself, there are disadvantages such as large dose, gastrointestinal irritation, easy to cause intestinal flora imbalance, slow onset of action, low bioavailability, long course of treatment, and low local drug concentration in the lesion, which cannot meet the needs of the unique drug in clinical practice. application on
[0006] Iridoid glycosides are the active ingredients of many traditional Chinese medicines, but so far, in domestic and foreign patent literature and non-patent literature, there is no report on the topical liquid preparation of unique iridoid glycosides

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Externally used liquid preparation containing only iridoid glycoside and application thereof
  • Externally used liquid preparation containing only iridoid glycoside and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Embodiment 1 The embodiment of unique total iridoid glycosides washing (wiping) agent

[0022] 1) Formula (dosage per 100ml)

[0023] Duyiwei Total Iridoid Glycosides 0.1g(0.1%)

[0024] Sterile water 99.9g (99.9%)

[0025] 2) Preparation method: Dissolve the total iridoid glycosides of the unique ingredient in the formula in water and mix well.

Embodiment 2

[0026] The implementation of embodiment 2 unique total iridoid glycosides washing (wiping) agent

[0027] 1) Formula (dosage per 100ml)

[0028] Duyiwei total iridoid glycosides 2g(2.0%)

[0029] Sterile water 98g (98.0%)

[0030] 2) Preparation method: Dissolve the total iridoid glycosides of the unique ingredient in the formula in water and mix well.

Embodiment 3

[0031] The embodiment of embodiment 3 unique total iridoid glycosides washing (wiping) agent

[0032] 1) Formula (dosage per 100ml)

[0033] Duyiwei total iridoid glycosides 49.99g(49.99.0%)

[0034] Sterile water 50.01g (50.01%)

[0035] 2) Preparation method: Dissolve the total iridoid glycosides of the unique ingredient in the formula in water and mix well.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an externally used liquid preparation containing only iridoid glycoside and application thereof, belonging to the field of medicine. The externally used preparation of the invention contains 0.10-49.99% of the iridoid glycoside as an effective component and balance of adjuvant and water for manufacturing externally used preparations. The formulation of the preparation is externally used liquid lotion, externally used liquid liniment, aerosol, ointment and spraying agent.

Description

technical field [0001] The invention relates to an external liquid preparation of a unique iridoid glycoside, in particular to a lotion, liniment, aerosol, spray and ointment of a unique iridoid glycoside. technical background [0002] Traditional analgesics are opioid analgesics represented by morphine and non-steroidal anti-inflammatory analgesics represented by aspirin, but the former has serious adverse reactions such as addiction and respiratory depression, and the latter also damages the stomach Intestinal side effects, can not be an ideal analgesic drug. In recent years, scholars at home and abroad have been very active in the research of finding high-efficiency, low-toxicity, and non-dependent analgesics from natural medicines. [0003] Duyiwei Lamiophlomis rotata (Benth.) Kudo is a plant of the Labiatae family, which originally belonged to the genus Cordyceps. Also known as "Big Bus" and "Da Bubba". Its roots, rhizomes or whole plants are used as medicine, and it...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/53A61K9/00A61K9/06A61K9/12A61K47/10A61K47/32A61K47/34A61K47/42
Inventor 阙文彬李育飞向妮
Owner HENGKANG MEDICAL GROUP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products